Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Canadian Association of Radiologists consensus guidelines for the prevention of contrast-induced nephropathy: update 2012.

Owen RJ, Hiremath S, Myers A, Fraser-Hill M, Barrett BJ.

Can Assoc Radiol J. 2014 May;65(2):96-105. doi: 10.1016/j.carj.2012.11.002. Epub 2014 Feb 20.

2.

Canadian Association of Radiologists: consensus guidelines for the prevention of contrast-induced nephropathy.

Benko A, Fraser-Hill M, Magner P, Capusten B, Barrett B, Myers A, Owen RJ; Canadian Association of Radiologists.

Can Assoc Radiol J. 2007 Apr;58(2):79-87.

PMID:
17521052
3.

Current concepts of contrast-induced nephropathy: a brief review.

Chang CF, Lin CC.

J Chin Med Assoc. 2013 Dec;76(12):673-81. doi: 10.1016/j.jcma.2013.08.011. Epub 2013 Oct 3. Review.

4.

Effectiveness of theophylline in preventing contrast-induced nephropathy after coronary angiographic procedures.

Bilasy ME, Oraby MA, Ismail HM, Maklady FA.

J Interv Cardiol. 2012 Aug;25(4):404-10. doi: 10.1111/j.1540-8183.2012.00730.x. Epub 2012 May 22.

PMID:
22612071
6.

Contrast-induced nephropathy--prevention and risk reduction.

Lameire NH.

Nephrol Dial Transplant. 2006 Jun;21(6):i11-23. Review.

PMID:
16723348
7.

Prevention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular procedures.

Schweiger MJ, Chambers CE, Davidson CJ, Blankenship J, Bhalla NP, Block PC, Dervan JP, Gasperetti C, Gerber L, Kleiman NS, Krone RJ, Phillips WJ, Siegel RM, Uretsky BF, Laskey WK.

Catheter Cardiovasc Interv. 2007 Jan;69(1):135-40. Review. Erratum in: Catheter Cardiovasc Interv. 2007 May 1;69(6):931. Zang, Shaoheng [removed].

PMID:
17139671
8.

Reducing the risks for contrast-induced nephropathy.

Stacul F.

Cardiovasc Intervent Radiol. 2005;28 Suppl 2:S12-8. Review.

PMID:
16419278
9.

Use of NaCl saline hydration and N-Acetyl Cysteine to prevent contrast induced nephropathy in different populations of patients at high and low risk undergoing coronary artery angiography.

Calabrò P, Bianchi R, Caprile M, Sordelli C, Cappelli Bigazzi M, Palmieri R, Gigantino G, Limongelli G, Capozzi G, Cuomo S, Calabrò R.

Minerva Cardioangiol. 2010 Feb;58(1):35-40.

PMID:
20145594
10.

Sodium bicarbonate versus normal saline for protection against contrast nephropathy.

Budhiraja P, Chen Z, Popovtzer M.

Ren Fail. 2009;31(2):118-23. doi: 10.1080/08860220802599239.

PMID:
19212908
11.

[Iodinated contrast agent-induced nephropathy].

Erley C.

Radiologe. 2007 Sep;47(9):761-7. Review. German.

PMID:
17823784
12.

Prevention of acute renal failure post-contrast imaging in cardiology: a randomized study.

Alessandri N, Lanzi L, Garante CM, Tersigni F, Sergiacomi R, Petrassi M, Di Matteo A, Tufano F.

Eur Rev Med Pharmacol Sci. 2013 Feb;17 Suppl 1:13-21.

13.

N-acetylcysteine versus N-acetylcysteine + theophylline for the prevention of contrast nephropathy.

Baskurt M, Okcun B, Abaci O, Dogan GM, Kilickesmez K, Ozkan AA, Ersanli M, Gurmen T.

Eur J Clin Invest. 2009 Sep;39(9):793-9. doi: 10.1111/j.1365-2362.2009.02173.x. Epub 2009 Jun 5.

PMID:
19500141
14.

Hydration with sodium bicarbonate does not prevent contrast nephropathy: a multicenter clinical trial.

Gomes VO, Lasevitch R, Lima VC, Brito FS Jr, Perez-Alva JC, Moulin B, Arruda A, Oliveira D, Caramori P.

Arq Bras Cardiol. 2012 Dec;99(6):1129-34. Epub 2012 Nov 27. English, Portuguese.

15.

[Prevention of contrast-induced nephropathy using cardiac catheterization combined with hydration, oral N-acetylcysteine, sodium bicarbonate and iso-osmolar contrast agents].

Hoshino A, Enomoto S, Kawahito H, Kurata H, Nakahara Y, Nakamura T.

J Cardiol. 2007 Aug;50(2):119-26. Japanese.

PMID:
17802695
16.

Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention.

Maioli M, Toso A, Leoncini M, Gallopin M, Tedeschi D, Micheletti C, Bellandi F.

J Am Coll Cardiol. 2008 Aug 19;52(8):599-604. doi: 10.1016/j.jacc.2008.05.026.

17.

Probability of reduced renal function after contrast-enhanced CT: a model based on serum creatinine level, patient age, and estimated glomerular filtration rate.

Herts BR, Schneider E, Obuchowski N, Poggio E, Jain A, Baker ME.

AJR Am J Roentgenol. 2009 Aug;193(2):494-500. doi: 10.2214/AJR.08.1908.

PMID:
19620448
18.

Contrast medium dose-to-GFR ratio: a measure of systemic exposure to predict contrast-induced nephropathy after percutaneous coronary intervention.

Nyman U, Björk J, Aspelin P, Marenzi G.

Acta Radiol. 2008 Jul;49(6):658-67. doi: 10.1080/02841850802050762.

PMID:
18568558
20.

[Contrast-induced nephropathy].

Santos RO, Malvar B, Silva R, Ramalho V, Pessegueiro P, Amoedo M, Aniceto J, Pires C.

Acta Med Port. 2011 Sep-Oct;24(5):809-20. Epub 2011 Dec 29. Review. Portuguese.

Supplemental Content

Support Center